We are live on ! Find out more
RCEL icon

Avita Medical
RCEL

80 hedge funds and large institutions have $129M invested in Avita Medical in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more capital invested

Capital invested by funds: $82.5M → $129M (+$47M)

56% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 16

53% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 17

13% more funds holding

Funds holding: 71 → 80 (+9)

10% more call options, than puts

Call options by funds: $1.1M | Put options by funds: $1M

6.75% more ownership

Funds ownership: 23.3% → 30.05% (+6.8%)

Holders
80
Holders Change
+9
Holders Change %
+12.68%
% of All Funds
1.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
25
Reduced
16
Closed
17
Calls
$1.1M
Puts
$1M
Net Calls
+$103K
Net Calls Change
+$88K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$17.4M
2
State Street
State Street
Massachusetts
+$5.35M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$3.3M
4
Russell Investments Group
Russell Investments Group
United Kingdom
+$3.16M
5
Northern Trust
Northern Trust
Illinois
+$2.55M

Top Sellers

Rank Fund Capital Flow
1
PVI
Pura Vida Investments
New York
-$5.47M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.2M
3
Jane Street
Jane Street
New York
-$1.97M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.65M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.53M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
26
Clearline Capital
New York
$856K – – –
AR
27
Advisory Research
Illinois
$801K +$691K +47,094 New
Creative Planning
28
Creative Planning
Kansas
$690K -$63.2K -4,305 -10%
MA
29
MCF Advisors
Kentucky
$626K – – –
Morgan Stanley
30
Morgan Stanley
New York
$613K -$303K -20,674 -36%
SO
31
STRS Ohio
Ohio
$612K +$528K +36,000 New
Goldman Sachs
32
Goldman Sachs
New York
$556K -$647K -44,108 -57%
SCM
33
Segantii Capital Management
Hong Kong
$510K +$440K +30,000 New
BCM
34
Bridgeway Capital Management
Texas
$485K – – –
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$460K +$397K +27,029 New
Marshall Wace
36
Marshall Wace
United Kingdom
$434K -$531K -36,215 -59%
JF
37
Jump Financial
Illinois
$417K +$33.7K +2,300 +10%
Man Group
38
Man Group
United Kingdom
$335K +$289K +19,688 New
JP Morgan Chase
39
JP Morgan Chase
New York
$332K +$188K +12,846 +193%
UBS Group
40
UBS Group
Switzerland
$297K +$168K +11,470 +191%
FAG
41
Financial Advisory Group
Texas
$291K – – –
T. Rowe Price Associates
42
T. Rowe Price Associates
Maryland
$240K +$51.3K +3,499 +33%
Simplex Trading
43
Simplex Trading
Illinois
$234K +$175K +11,951 +648%
MIM
44
MetLife Investment Management
New Jersey
$232K +$200K +13,645 New
CSS
45
Cubist Systematic Strategies
Connecticut
$230K +$15.8K +1,080 +9%
American Century Companies
46
American Century Companies
Missouri
$215K +$185K +12,620 New
Wells Fargo
47
Wells Fargo
California
$213K +$151K +10,270 +462%
Mirae Asset Global Investments
48
Mirae Asset Global Investments
South Korea
$211K +$182K +12,416 New
AIG
49
American International Group
New York
$206K +$178K +12,100 New
Deutsche Bank
50
Deutsche Bank
Germany
$193K +$167K +11,349 New
1
2
3 4

RCEL Hedge Fund Activity: Q2 2023 in Review

80 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q2 2023, worth a combined $129M — up 57% from $82.5M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new RCEL positions and 17 closed out — a net gain of 9 holders — while 25 added to existing stakes and 16 trimmed.

The largest buyer was BlackRock, adding an estimated $17.4M. The largest seller was Pura Vida Investments, cutting an estimated $5.47M.

  • 80 institutional investors held Avita Medical (RCEL) as of Q2 2023, up from 71 in Q1 2023.
  • Funds reported $129M of Avita Medical stock for Q2 2023, up 57% quarter-over-quarter.
  • 26 funds opened new Avita Medical positions in Q2 2023 and 17 closed out, a net change of +9 holders.
  • The largest Avita Medical buyer in Q2 2023 was BlackRock, an estimated $17.4M added.
  • The largest Avita Medical seller in Q2 2023 was Pura Vida Investments, an estimated $5.47M sold.

Based on aggregated 13F filings for Q2 2023.